FluoroPharma Medical Inc (FPMI)
0.0001
0.00 (0.00%)
USD |
OTCM |
Sep 27, 16:00
FluoroPharma Medical Research and Development Expense (TTM): 0.5551M for Dec. 31, 2016
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| December 31, 2016 | 0.5551M |
| September 30, 2016 | 0.5952M |
| June 30, 2016 | 0.865M |
| March 31, 2016 | 0.7281M |
| December 31, 2015 | 0.7209M |
| September 30, 2015 | 1.097M |
| June 30, 2015 | 1.447M |
| March 31, 2015 | 1.611M |
| December 31, 2014 | 1.754M |
| September 30, 2014 | 1.566M |
| June 30, 2014 | 1.247M |
| March 31, 2014 | 1.346M |
| Date | Value |
|---|---|
| December 31, 2013 | 1.312M |
| September 30, 2013 | 1.498M |
| June 30, 2013 | 1.520M |
| March 31, 2013 | 1.419M |
| December 31, 2012 | 1.423M |
| September 30, 2012 | 1.290M |
| June 30, 2012 | 0.9558M |
| March 31, 2012 | 0.936M |
| December 31, 2011 | 0.6407M |
| September 30, 2011 | 0.2296M |
| June 30, 2011 | 0.2414M |
| March 31, 2011 | 0.0279M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Athersys Inc | 29.98M |
| Ampio Pharmaceuticals Inc | 2.439M |
| Evolutionary Genomics Inc | 0.4175M |
| MetaStat Inc | 1.451M |
| Xeno Transplants Corp | -- |